Clinical Trial Update: BREVOC Study: Exhaled VOCs for High-Risk Chest Pain in the ED

View source ↗

Summary

Clinical trial update for the BREVOC study evaluating exhaled volatile organic compounds for high-risk chest pain and acute coronary syndrome in the emergency d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Acute Coronary Syndrome, High-Risk Chest Pain | Status: NOT_YET_RECRUITING